Market Place
Sourcing Support
Endo Launches New Peyronie`s Disease Campaign: I Got Somebody
13 Jan 2025 //
PR NEWSWIRE
Endo Publishes Peyronie’s Disease Screening App Article
16 Dec 2024 //
PR NEWSWIRE
Endo Launches Doxycycline for Injection, USP
10 Dec 2024 //
PR NEWSWIRE
Endo Receives US FDA Approval for Manufacturing Facility in India
09 Dec 2024 //
PR NEWSWIRE
John with Endo on Dupuytren`s Contracture Treatment with XIAFLEX®
20 Nov 2024 //
PR NEWSWIRE
Endo Expands Voluntary Recall of Clonazepam Due to Mislabeling
18 Nov 2024 //
PR NEWSWIRE
Endo Partners Paladin Pharma to Commercialize Wynzora in Canada
15 Nov 2024 //
PR NEWSWIRE
Endo Reports Q3 2024 Financial Results & Expectations
05 Nov 2024 //
PR NEWSWIRE
Endo Presents Peyronie`s Disease Data at SurgeWest Annual Meeting
25 Oct 2024 //
PR NEWSWIRE
After guiding Endo through bankruptcy, CEO Blaise Coleman exits suddenly
27 Aug 2024 //
FIERCE PHARMA
ENDO ANNOUNCES CEO TRANSITION
27 Aug 2024 //
PR NEWSWIRE
ENDO REPORTS SECOND-QUARTER 2024 FINANCIAL RESULTS
27 Aug 2024 //
PR NEWSWIRE
Endo to Host Investor Call on Second Quarter 2024 Financial Results
07 Aug 2024 //
PR NEWSWIRE
Pharma is Missing the Mark: Social Media`s Power Proven by Physician Influencers
15 Jul 2024 //
PR NEWSWIRE
Endo Announces Commencement of OTCQX Trading
28 Jun 2024 //
PR NEWSWIRE
DC appeals court dismisses FTC case against Endo and Impax`s opioid agreement
28 Aug 2023 //
ENDPTS
Enforcement Report - Week of June 7, 2023
07 Jun 2023 //
FDA
Endo plays it straight with new Peyronie`s disease tool
28 Oct 2022 //
FIERCEPHARMA
Executive bonuses at Malvern opioid firm Endo were ‘excessive’ and ‘secret’
23 Sep 2022 //
INQUIRER
Alabama settles for $276M with McKesson, J&J and Endo over opioid crisis
19 Apr 2022 //
ENDPTS
Endo Begins Shipment of Premixed Ephedrine Sulfate Injection
28 Mar 2022 //
PRNEWSWIRE
Endo Launches New Living Our Values Program for Outstanding Team Members
03 Mar 2022 //
PRNEWSWIRE
ENDO REPORTS FOURTH-QUARTER AND FULL-YEAR 2021 FINANCIAL RESULTS
28 Feb 2022 //
PRNEWSWIRE
Endo Comments on Default Judgment on Liability in Tennessee State Court
11 Feb 2022 //
PRNEWSWIRE
Strides Pharma banks on acquired Endo portfolio for turnaround of US business
11 Feb 2022 //
ECONOMIC TIMES
Endo pivots from NFL star to real patients in Dupuytren’s contract
11 Jan 2022 //
ENDPTS
FDA seeks FTC action after rejecting petition to block vasopressin`s generic
17 Dec 2021 //
ENDPTS
Endo, U.S. Govt. Enter Fill-Finish Mfg. Pact
17 Nov 2021 //
CONTRACTPHARMA
Endo uses carrots to launch ads for Peyronie`s med Xiaflex
06 Nov 2021 //
FIERCEPHARMA
J&J, AbbVie, Teva and Endo score first opioid trial victory
02 Nov 2021 //
FIERCEPHARMA
Strides Pharma acquires new manufacturing site
01 Nov 2021 //
ENDPTS
Long-term opioid deal suits cash-strapped Teva
30 Sep 2021 //
FIERCEPHARMA
FDA puts India`s Wintac on blast for lackadaisical probe into contamination
26 Aug 2020 //
FIERCEPHARMA
Morton Grove`s Withdrawal of Approval of 21 Abbreviated New Drug Applications
02 Dec 2019 //
FEDERALREGISTER
Nixed Pfallergan Deal Has Investors Wondering if Allergan Might Target Biogen
06 Apr 2016 //
BIOSPACE
Vernalis cuts the cord on a late-stage pain drug after a trial flop
22 Aug 2015 //
FIERCE BIOTECH
J&J, Endo, Teva and Actavis off the hook in Chicago painkiller lawsuit
12 May 2015 //
FIERCE PHARMA
Meet Pharma’s Newest Movers and Shakers
25 Apr 2015 //
THE WALL STREET JOURNAL
Novel Abuse Deterrent Formulation Technologies and Emergence of Novel Mechanism in the Management of Pain
04 Feb 2015 //
RESEARCH AND MARKETS
